These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
338 related items for PubMed ID: 16230178
21. Effect of nonsteroidal antiandrogen monotherapy versus castration therapy on neuroendocrine differentiation in prostate carcinoma. Sciarra A, Di Silverio F. Urology; 2004 Mar; 63(3):523-7. PubMed ID: 15028450 [Abstract] [Full Text] [Related]
29. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression. Cox ME, Deeble PD, Lakhani S, Parsons SJ. Cancer Res; 1999 Aug 01; 59(15):3821-30. PubMed ID: 10447001 [Abstract] [Full Text] [Related]
30. [Relationship of neuroendocrine differentiation to biological behavior of prostate cancer]. Wu XL, Huang KT, Chen W, Chen L, Dong L, Yu ZX. Zhonghua Yi Xue Za Zhi; 2009 Feb 24; 89(7):472-5. PubMed ID: 19567097 [Abstract] [Full Text] [Related]
31. NeuroD1 expression in human prostate cancer: can it contribute to neuroendocrine differentiation comprehension? Cindolo L, Franco R, Cantile M, Schiavo G, Liguori G, Chiodini P, Salzano L, Autorino R, Di Blasi A, Falsaperla M, Feudale E, Botti G, Gallo A, Cillo C. Eur Urol; 2007 Nov 24; 52(5):1365-73. PubMed ID: 17126478 [Abstract] [Full Text] [Related]
33. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia. Zhao Z, Liu J, Li S, Shen W. Prostate; 2009 Sep 01; 69(12):1292-302. PubMed ID: 19462463 [Abstract] [Full Text] [Related]
34. Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease. Berruti A, Mosca A, Tucci M, Terrone C, Torta M, Tarabuzzi R, Russo L, Cracco C, Bollito E, Scarpa RM, Angeli A, Dogliotti L. Endocr Relat Cancer; 2005 Mar 01; 12(1):109-17. PubMed ID: 15788643 [Abstract] [Full Text] [Related]
37. The androgen receptor status of neuroendocrine cells in human benign and malignant prostatic tissue. Nakada SY, di Sant'Agnese PA, Moynes RA, Hiipakka RA, Liao S, Cockett AT, Abrahamsson PA. Cancer Res; 1993 May 01; 53(9):1967-70. PubMed ID: 8481896 [Abstract] [Full Text] [Related]
38. Morphologic and neuroendocrine features of adenocarcinoma arising in the transition zone and in the peripheral zone of the prostate. Van de Voorde WM, Van Poppel HP, Verbeken EK, Oyen RH, Baert LV, Lauweryns JM. Mod Pathol; 1995 Aug 01; 8(6):591-8. PubMed ID: 8532689 [Abstract] [Full Text] [Related]
39. Divergent neuroendocrine differentiation in prostatic carcinoma. di Sant' Agnese PA. Semin Diagn Pathol; 2000 May 01; 17(2):149-61. PubMed ID: 10839615 [Abstract] [Full Text] [Related]
40. Neuroendocrine differentiation in extrahepatic bile duct carcinomas and its prognostic significance. Hong SM, Kim MJ, Pi DY, Jo D, Yu E, Ro JY. Hum Pathol; 2005 Jul 01; 36(7):732-40. PubMed ID: 16084941 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]